Clinical trial
Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune…
NCT00051311 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00051311 |
|---|---|
| Title | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers |
| Official title | A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, With Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematologic Neoplasms |
| Intervention type | Drug, Procedure |
| Interventions | Stem cell transplantation, Fludarabine, Cyclophosphamide, Etoposide, Doxorubicin, Vincristine, Prednisone, Methotrexate, Cyclosporine, Apheresis |
| Enrollment | 62 |
| Start date | Jan 3, 2003 |
| Primary completion | Sep 25, 2014 |
| Completion | Sep 25, 2014 |
| First posted | Jan 8, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: